Medical Care
Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Research Report 2025
- Jan 17, 26
- ID: 676491
- Pages: 75
- Figures: 74
- Views: 6
This report aims to provide a comprehensive presentation of the global market for Radioisotopes for Nuclear Medicine Diagnosis and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radioisotopes for Nuclear Medicine Diagnosis and Treatment.
The Radioisotopes for Nuclear Medicine Diagnosis and Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radioisotopes for Nuclear Medicine Diagnosis and Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
China National Nuclear Corporation (CNNC)
IRE ELIT
Nordion
Polatom
Segment by Type
Carbon-14
Technetium-99m
Iodine-131
Iodine-125
Others
Segment by Application
Nuclear Medicine Diagnosis
Nuclear Medicine Treatment
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radioisotopes for Nuclear Medicine Diagnosis and Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Radioisotopes for Nuclear Medicine Diagnosis and Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radioisotopes for Nuclear Medicine Diagnosis and Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
China National Nuclear Corporation (CNNC)
IRE ELIT
Nordion
Polatom
Segment by Type
Carbon-14
Technetium-99m
Iodine-131
Iodine-125
Others
Segment by Application
Nuclear Medicine Diagnosis
Nuclear Medicine Treatment
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radioisotopes for Nuclear Medicine Diagnosis and Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Carbon-14
1.2.3 Technetium-99m
1.2.4 Iodine-131
1.2.5 Iodine-125
1.2.6 Others
1.3 Market by Application
1.3.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Nuclear Medicine Diagnosis
1.3.3 Nuclear Medicine Treatment
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Perspective (2020-2031)
2.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Growth Trends by Region
2.2.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Historic Market Size by Region (2020-2025)
2.2.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Region (2026-2031)
2.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Dynamics
2.3.1 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Industry Trends
2.3.2 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Drivers
2.3.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Challenges
2.3.4 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players by Revenue
3.1.1 Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players by Revenue (2020-2025)
3.1.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue
3.4 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Concentration Ratio
3.4.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue in 2024
3.5 Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment Head office and Area Served
3.6 Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Product and Application
3.7 Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Breakdown Data by Type
4.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Historic Market Size by Type (2020-2025)
4.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Type (2026-2031)
5 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Breakdown Data by Application
5.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Historic Market Size by Application (2020-2025)
5.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2020-2031)
6.2 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2020-2025)
6.4 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2020-2031)
7.2 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2020-2025)
7.4 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2020-2031)
8.2 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2020-2031)
9.2 Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2020-2025)
9.4 Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2020-2031)
10.2 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NRG
11.1.1 NRG Company Details
11.1.2 NRG Business Overview
11.1.3 NRG Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.1.4 NRG Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
11.1.5 NRG Recent Development
11.2 NTP Radioisotopes
11.2.1 NTP Radioisotopes Company Details
11.2.2 NTP Radioisotopes Business Overview
11.2.3 NTP Radioisotopes Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.2.4 NTP Radioisotopes Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
11.2.5 NTP Radioisotopes Recent Development
11.3 JSC Isotope
11.3.1 JSC Isotope Company Details
11.3.2 JSC Isotope Business Overview
11.3.3 JSC Isotope Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.3.4 JSC Isotope Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
11.3.5 JSC Isotope Recent Development
11.4 ANSTO
11.4.1 ANSTO Company Details
11.4.2 ANSTO Business Overview
11.4.3 ANSTO Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.4.4 ANSTO Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
11.4.5 ANSTO Recent Development
11.5 China National Nuclear Corporation (CNNC)
11.5.1 China National Nuclear Corporation (CNNC) Company Details
11.5.2 China National Nuclear Corporation (CNNC) Business Overview
11.5.3 China National Nuclear Corporation (CNNC) Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.5.4 China National Nuclear Corporation (CNNC) Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
11.5.5 China National Nuclear Corporation (CNNC) Recent Development
11.6 IRE ELIT
11.6.1 IRE ELIT Company Details
11.6.2 IRE ELIT Business Overview
11.6.3 IRE ELIT Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.6.4 IRE ELIT Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
11.6.5 IRE ELIT Recent Development
11.7 Nordion
11.7.1 Nordion Company Details
11.7.2 Nordion Business Overview
11.7.3 Nordion Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.7.4 Nordion Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
11.7.5 Nordion Recent Development
11.8 Polatom
11.8.1 Polatom Company Details
11.8.2 Polatom Business Overview
11.8.3 Polatom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.8.4 Polatom Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
11.8.5 Polatom Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Carbon-14
1.2.3 Technetium-99m
1.2.4 Iodine-131
1.2.5 Iodine-125
1.2.6 Others
1.3 Market by Application
1.3.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Nuclear Medicine Diagnosis
1.3.3 Nuclear Medicine Treatment
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Perspective (2020-2031)
2.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Growth Trends by Region
2.2.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Historic Market Size by Region (2020-2025)
2.2.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Region (2026-2031)
2.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Dynamics
2.3.1 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Industry Trends
2.3.2 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Drivers
2.3.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Challenges
2.3.4 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players by Revenue
3.1.1 Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players by Revenue (2020-2025)
3.1.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue
3.4 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Concentration Ratio
3.4.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue in 2024
3.5 Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment Head office and Area Served
3.6 Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Product and Application
3.7 Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Breakdown Data by Type
4.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Historic Market Size by Type (2020-2025)
4.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Type (2026-2031)
5 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Breakdown Data by Application
5.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Historic Market Size by Application (2020-2025)
5.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2020-2031)
6.2 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2020-2025)
6.4 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2020-2031)
7.2 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2020-2025)
7.4 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2020-2031)
8.2 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2020-2031)
9.2 Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2020-2025)
9.4 Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2020-2031)
10.2 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NRG
11.1.1 NRG Company Details
11.1.2 NRG Business Overview
11.1.3 NRG Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.1.4 NRG Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
11.1.5 NRG Recent Development
11.2 NTP Radioisotopes
11.2.1 NTP Radioisotopes Company Details
11.2.2 NTP Radioisotopes Business Overview
11.2.3 NTP Radioisotopes Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.2.4 NTP Radioisotopes Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
11.2.5 NTP Radioisotopes Recent Development
11.3 JSC Isotope
11.3.1 JSC Isotope Company Details
11.3.2 JSC Isotope Business Overview
11.3.3 JSC Isotope Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.3.4 JSC Isotope Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
11.3.5 JSC Isotope Recent Development
11.4 ANSTO
11.4.1 ANSTO Company Details
11.4.2 ANSTO Business Overview
11.4.3 ANSTO Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.4.4 ANSTO Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
11.4.5 ANSTO Recent Development
11.5 China National Nuclear Corporation (CNNC)
11.5.1 China National Nuclear Corporation (CNNC) Company Details
11.5.2 China National Nuclear Corporation (CNNC) Business Overview
11.5.3 China National Nuclear Corporation (CNNC) Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.5.4 China National Nuclear Corporation (CNNC) Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
11.5.5 China National Nuclear Corporation (CNNC) Recent Development
11.6 IRE ELIT
11.6.1 IRE ELIT Company Details
11.6.2 IRE ELIT Business Overview
11.6.3 IRE ELIT Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.6.4 IRE ELIT Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
11.6.5 IRE ELIT Recent Development
11.7 Nordion
11.7.1 Nordion Company Details
11.7.2 Nordion Business Overview
11.7.3 Nordion Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.7.4 Nordion Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
11.7.5 Nordion Recent Development
11.8 Polatom
11.8.1 Polatom Company Details
11.8.2 Polatom Business Overview
11.8.3 Polatom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.8.4 Polatom Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
11.8.5 Polatom Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Carbon-14
Table 3. Key Players of Technetium-99m
Table 4. Key Players of Iodine-131
Table 5. Key Players of Iodine-125
Table 6. Key Players of Others
Table 7. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Region (2020-2025)
Table 11. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Region (2026-2031)
Table 13. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Trends
Table 14. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Drivers
Table 15. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Challenges
Table 16. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Restraints
Table 17. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Players (2020-2025)
Table 19. Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment as of 2024)
Table 20. Ranking of Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Headquarters and Area Served
Table 23. Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Product and Application
Table 24. Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Type (2020-2025)
Table 28. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Type (2026-2031)
Table 30. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Application (2020-2025)
Table 32. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Application (2026-2031)
Table 34. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 49. NRG Company Details
Table 50. NRG Business Overview
Table 51. NRG Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 52. NRG Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 53. NRG Recent Development
Table 54. NTP Radioisotopes Company Details
Table 55. NTP Radioisotopes Business Overview
Table 56. NTP Radioisotopes Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 57. NTP Radioisotopes Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 58. NTP Radioisotopes Recent Development
Table 59. JSC Isotope Company Details
Table 60. JSC Isotope Business Overview
Table 61. JSC Isotope Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 62. JSC Isotope Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 63. JSC Isotope Recent Development
Table 64. ANSTO Company Details
Table 65. ANSTO Business Overview
Table 66. ANSTO Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 67. ANSTO Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 68. ANSTO Recent Development
Table 69. China National Nuclear Corporation (CNNC) Company Details
Table 70. China National Nuclear Corporation (CNNC) Business Overview
Table 71. China National Nuclear Corporation (CNNC) Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 72. China National Nuclear Corporation (CNNC) Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 73. China National Nuclear Corporation (CNNC) Recent Development
Table 74. IRE ELIT Company Details
Table 75. IRE ELIT Business Overview
Table 76. IRE ELIT Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 77. IRE ELIT Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 78. IRE ELIT Recent Development
Table 79. Nordion Company Details
Table 80. Nordion Business Overview
Table 81. Nordion Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 82. Nordion Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 83. Nordion Recent Development
Table 84. Polatom Company Details
Table 85. Polatom Business Overview
Table 86. Polatom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 87. Polatom Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 88. Polatom Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
Table 92. Authors List of This Report
List of Figures
Figure 1. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Picture
Figure 2. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Type: 2024 VS 2031
Figure 4. Carbon-14 Features
Figure 5. Technetium-99m Features
Figure 6. Iodine-131 Features
Figure 7. Iodine-125 Features
Figure 8. Others Features
Figure 9. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Application: 2024 VS 2031
Figure 11. Nuclear Medicine Diagnosis Case Studies
Figure 12. Nuclear Medicine Treatment Case Studies
Figure 13. Others Case Studies
Figure 14. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Report Years Considered
Figure 15. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Region: 2024 VS 2031
Figure 18. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Players in 2024
Figure 19. Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue in 2024
Figure 21. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Country (2020-2031)
Figure 23. United States Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Country (2020-2031)
Figure 27. Germany Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Region (2020-2031)
Figure 35. China Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Country (2020-2031)
Figure 43. Mexico Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Country (2020-2031)
Figure 47. Turkey Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. NRG Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
Figure 51. NTP Radioisotopes Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
Figure 52. JSC Isotope Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
Figure 53. ANSTO Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
Figure 54. China National Nuclear Corporation (CNNC) Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
Figure 55. IRE ELIT Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
Figure 56. Nordion Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
Figure 57. Polatom Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Carbon-14
Table 3. Key Players of Technetium-99m
Table 4. Key Players of Iodine-131
Table 5. Key Players of Iodine-125
Table 6. Key Players of Others
Table 7. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Region (2020-2025)
Table 11. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Region (2026-2031)
Table 13. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Trends
Table 14. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Drivers
Table 15. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Challenges
Table 16. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Restraints
Table 17. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Players (2020-2025)
Table 19. Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment as of 2024)
Table 20. Ranking of Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Headquarters and Area Served
Table 23. Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Product and Application
Table 24. Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Type (2020-2025)
Table 28. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Type (2026-2031)
Table 30. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Application (2020-2025)
Table 32. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Application (2026-2031)
Table 34. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 49. NRG Company Details
Table 50. NRG Business Overview
Table 51. NRG Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 52. NRG Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 53. NRG Recent Development
Table 54. NTP Radioisotopes Company Details
Table 55. NTP Radioisotopes Business Overview
Table 56. NTP Radioisotopes Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 57. NTP Radioisotopes Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 58. NTP Radioisotopes Recent Development
Table 59. JSC Isotope Company Details
Table 60. JSC Isotope Business Overview
Table 61. JSC Isotope Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 62. JSC Isotope Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 63. JSC Isotope Recent Development
Table 64. ANSTO Company Details
Table 65. ANSTO Business Overview
Table 66. ANSTO Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 67. ANSTO Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 68. ANSTO Recent Development
Table 69. China National Nuclear Corporation (CNNC) Company Details
Table 70. China National Nuclear Corporation (CNNC) Business Overview
Table 71. China National Nuclear Corporation (CNNC) Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 72. China National Nuclear Corporation (CNNC) Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 73. China National Nuclear Corporation (CNNC) Recent Development
Table 74. IRE ELIT Company Details
Table 75. IRE ELIT Business Overview
Table 76. IRE ELIT Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 77. IRE ELIT Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 78. IRE ELIT Recent Development
Table 79. Nordion Company Details
Table 80. Nordion Business Overview
Table 81. Nordion Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 82. Nordion Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 83. Nordion Recent Development
Table 84. Polatom Company Details
Table 85. Polatom Business Overview
Table 86. Polatom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 87. Polatom Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 88. Polatom Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
Table 92. Authors List of This Report
List of Figures
Figure 1. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Picture
Figure 2. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Type: 2024 VS 2031
Figure 4. Carbon-14 Features
Figure 5. Technetium-99m Features
Figure 6. Iodine-131 Features
Figure 7. Iodine-125 Features
Figure 8. Others Features
Figure 9. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Application: 2024 VS 2031
Figure 11. Nuclear Medicine Diagnosis Case Studies
Figure 12. Nuclear Medicine Treatment Case Studies
Figure 13. Others Case Studies
Figure 14. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Report Years Considered
Figure 15. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Region: 2024 VS 2031
Figure 18. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Players in 2024
Figure 19. Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue in 2024
Figure 21. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Country (2020-2031)
Figure 23. United States Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Country (2020-2031)
Figure 27. Germany Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Region (2020-2031)
Figure 35. China Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Country (2020-2031)
Figure 43. Mexico Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Country (2020-2031)
Figure 47. Turkey Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. NRG Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
Figure 51. NTP Radioisotopes Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
Figure 52. JSC Isotope Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
Figure 53. ANSTO Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
Figure 54. China National Nuclear Corporation (CNNC) Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
Figure 55. IRE ELIT Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
Figure 56. Nordion Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
Figure 57. Polatom Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232